Authors

• Gerhardt Attard (ORCID: https://orcid.org/0000-0002-4811-7983)
• Dana E. Rathkopf (ORCID: https://orcid.org/0000-0002-4503-7582)
• Kim N. Chi (ORCID: https://orcid.org/0000-0002-3782-7226)
• Eric Jay Small (ORCID: https://orcid.org/0000-0003-3191-6268)
• Gary Mason (ORCID: https://orcid.org/0000-0002-3023-687X)
• Bogdan Żurawski
• V.S. Sakalo (ORCID: https://orcid.org/0000-0002-8340-6895)
• Angela Lopez‐Gitlitz (ORCID: https://orcid.org/0000-0003-3323-7605)
• Andrea Juliana Gomes (ORCID: https://orcid.org/0000-0001-7388-663X)
• Brooke Diorio
• Peter Francis (ORCID: https://orcid.org/0000-0003-3159-0851)
• Daphne Wu (ORCID: https://orcid.org/0000-0002-6700-9996)
• Ji Youl Lee (ORCID: https://orcid.org/0000-0001-6775-1157)
• Shahneen Kaur Sandhu (ORCID: https://orcid.org/0000-0002-8660-4475)
• Guilhem Roubaud
• David Olmos (ORCID: https://orcid.org/0000-0002-7003-4826)
• Eleni Efstathiou (ORCID: https://orcid.org/0000-0002-3868-1396)
• George Wang (ORCID: https://orcid.org/0000-0003-3593-5925)
• Matthew R. Smith (ORCID: https://orcid.org/0000-0001-5207-2370)
• Marniza Saad (ORCID: https://orcid.org/0000-0003-3768-4808)

Institutions

• Houston Methodist (US)
• Memorial Sloan Kettering Cancer Center (US)
• Harvard University (US)
• University of British Columbia (CA)
• The University of Melbourne (AU)
• University of California, San Francisco (US)
• Cornell University (US)
• Peter MacCallum Cancer Centre (AU)
• University of Malaya (MY)
• Massachusetts General Hospital (US)
• Hospital Universitario 12 De Octubre (ES)
• State Institution «Academician O.F.Vozianov Institute of Urology of the National Academy of Medical Sciences of Ukraine» (UA)
• Institut Bergonié (FR)
• The London College (GB)
• Kyiv City Clinical Oncology Center (UA)
• Janssen (United States) (US)
• The Catholic University of Korea Seoul St. Mary's Hospital (KR)
• UCSF Helen Diller Family Comprehensive Cancer Center (US)
• University College London (GB)
• Catholic University of Korea (KR)

Publication Details

Journal

Future Oncology

Published

2025-03-30

DOI

https://doi.org/10.1080/14796694.2025.2470106

Primary Topic

PARP inhibition in cancer therapy

Type

article

Field-Weighted Citation Impact

0.00